Recent studies have shown symptomatic, pregnant patients with COVID-19 are at increased risk for more severe disease, ICU admission, mechanical ventilation and death than nonpregnant patients, according to William Hartman, MD, PhD, a principal investigator for AstraZeneca’s COVID-19 vaccine trial at the University of Wisconsin’s Madison campus and an assistant professor of anesthesiology.
University Communications